CMS Statement on Proposed Local Coverage Determination (LCD) for Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers
CMS is aware that on April 25, 2024, the Medicare Administrative Contractors (MACs) released a
Press ReleasesShort-Term, Limited-Duration Insurance and Independent, Noncoordinated Excepted Benefits Coverage (CMS-9904-F) Fact Sheet
On March 28, 2024, the Departments of Health and Human Services (HHS), Labor, and the Treasury
Fact SheetsBiden-Harris Administration Protects Consumers from Low-Quality Coverage by Limiting “Junk” Health Plans
These actions build on the Biden-Harris Administration’s effort to eliminate hidden fees and consumer traps in every sector of the economy.
Press ReleasesCMS Statement on Current Status of Blood Tests for Organ Transplant Rejection
Statement: Patients with transplanted hearts, lungs, or kidneys who meet Medicare’s local coverage
Press ReleasesCMS Provides Critical Tools to Help Improve Access for Millions who Receive Medicaid Home- and Community-based Services
New guidance outlines how states can establish important tools to connect individuals needing care
Press ReleasesHHS Takes Action to Provide 12 Months of Mandatory Continuous Coverage for Children in Medicaid and CHIP
Letter sent to state health officials in all 50 states, D.C., and US territories
Press ReleasesCMS Statement on Current Status of Blood Tests for Organ Transplant Rejection
Important: On 2/29/2024 CMS issued an updated statement on this issue. For more information go here
Press ReleasesShort-Term, Limited-Duration Insurance; Independent, Noncoordinated Excepted Benefits Coverage; Level-Funded Plan Arrangements; and Tax Treatment of Certain Accident and Health Insurance (CMS-9904-P)
On July 7, 2023, the Department of Health and Human Services (HHS), the Department of Labor, and the
Fact SheetsStatement: Broader Medicare Coverage of Leqembi Available Following FDA Traditional Approval
Broader Medicare coverage is now available for Biogen and Eisai’s Leqembi (the brand name for
Press ReleasesNotice with Comment - Transitional Coverage for Emerging Technologies (CMS-3421-NC)
The Centers for Medicare & Medicaid Services (CMS) issued a proposed procedural notice outlining a
Fact Sheets